Literature DB >> 19259663

PET imaging of HSV1-tk mutants with acquired specificity toward pyrimidine- and acycloguanosine-based radiotracers.

Yury Likar1, Konstantin Dobrenkov, Malgorzata Olszewska, Larissa Shenker, Shangde Cai, Hedvig Hricak, Vladimir Ponomarev.   

Abstract

PURPOSE: The aim of this study was to create an alternative mutant of the herpes simplex virus type 1 thymidine kinase (HSV1-tk) reporter gene with reduced phosphorylation capacity for acycloguanosine derivatives, but not pyrimidine-based compounds that will allow for successful PET imaging.
METHODS: A new mutant of HSV1-tk reporter gene, suitable for PET imaging using pyrimidine-based radiotracers, was developed. The HSV1-tk mutant contains an arginine-to-glutamine substitution at position 176 (HSV1-R176Qtk) of the nucleoside binding region of the enzyme.
RESULTS: The mutant-gene product showed favorable enzymatic characteristics toward pyrimidine-based nucleosides, while exhibiting reduced activity with acycloguanosine derivatives. In order to enhance HSV1-R176Qtk reporter activity with pyrimidine-based radiotracers, we introduced the R176Q substitution into the more active HSV1-sr39tk mutant. U87 human glioma cells transduced with the HSV1-R176Qsr39tk double mutant reporter gene showed high (3)H-FEAU pyrimidine nucleoside and low (3)H-penciclovir acycloguanosine analog uptake in vitro. PET imaging also demonstrated high (18)F-FEAU and low (18)F-FHBG accumulation in HSV1-R176Qsr39tk+ xenografts. The feasibility of imaging two independent nucleoside-specific HSV1-tk mutants in the same animal with PET was demonstrated. Two opposite xenografts expressing the HSV1-R176Qsr39tk reporter gene and the previously described acycloguanosine-specific mutant of HSV1-tk, HSV1-A167Ysr39tk reporter gene, were imaged using a short-lived pyrimidine-based (18)F-FEAU and an acycloguanosine-based (18)F-FHBG radiotracer, respectively, administered on 2 consecutive days.
CONCLUSION: We conclude that in combination with acycloguanosine-specific HSV1-A167Ysr39tk reporter gene, a HSV1-tk mutant containing the R176Q substitution could be used for PET imaging of two different cell populations or concurrent molecular biological processes in the same living subject.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19259663      PMCID: PMC4416642          DOI: 10.1007/s00259-009-1089-x

Source DB:  PubMed          Journal:  Eur J Nucl Med Mol Imaging        ISSN: 1619-7070            Impact factor:   9.236


  40 in total

1.  Comparison of [18F]FHPG and [124/125I]FIAU for imaging herpes simplex virus type 1 thymidine kinase gene expression.

Authors:  P Brust; R Haubner; A Friedrich; M Scheunemann; M Anton; O N Koufaki; M Hauses; S Noll; B Noll; U Haberkorn; G Schackert; H K Schackert; N Avril; B Johannsen
Journal:  Eur J Nucl Med       Date:  2001-06

2.  Herpes simplex virus-1 thymidine kinase mutants created by semi-random sequence mutagenesis improve prodrug-mediated tumor cell killing.

Authors:  M E Black; M S Kokoris; P Sabo
Journal:  Cancer Res       Date:  2001-04-01       Impact factor: 12.701

3.  Evaluation of 9-[(3-18F-fluoro-1-hydroxy-2-propoxy)methyl]guanine ([18F]-FHPG) in vitro and in vivo as a probe for PET imaging of gene incorporation and expression in tumors.

Authors:  M M Alauddin; A Shahinian; R K Kundu; E M Gordon; P S Conti
Journal:  Nucl Med Biol       Date:  1999-05       Impact factor: 2.408

4.  Imaging TCR-dependent NFAT-mediated T-cell activation with positron emission tomography in vivo.

Authors:  V Ponomarev; M Doubrovin; C Lyddane; T Beresten; J Balatoni; W Bornman; R Finn; T Akhurst; S Larson; R Blasberg; M Sadelain; J G Tjuvajev
Journal:  Neoplasia       Date:  2001 Nov-Dec       Impact factor: 5.715

5.  SPECT imaging of herpes simplex virus type1 thymidine kinase gene expression by [(123)I]FIAU(1).

Authors:  Seok Rye Choi; Zhi-Ping Zhuang; Ann-Marie Chacko; Paul D Acton; Juri Tjuvajev-Gelovani; Mikhai Doubrovin; David C K Chu; Hank F Kung
Journal:  Acad Radiol       Date:  2005-07       Impact factor: 3.173

6.  Comparison of radiolabeled nucleoside probes (FIAU, FHBG, and FHPG) for PET imaging of HSV1-tk gene expression.

Authors:  Juri Gelovani Tjuvajev; Mikhail Doubrovin; Timothy Akhurst; Shangde Cai; Julius Balatoni; Mian M Alauddin; Ronald Finn; William Bornmann; Howard Thaler; Peter S Conti; Ronald G Blasberg
Journal:  J Nucl Med       Date:  2002-08       Impact factor: 10.057

7.  Comparison of [18F]FHBG and [14C]FIAU for imaging of HSV1-tk reporter gene expression: adenoviral infection vs stable transfection.

Authors:  Jung-Jun Min; Meera Iyer; Sanjiv S Gambhir
Journal:  Eur J Nucl Med Mol Imaging       Date:  2003-07-10       Impact factor: 9.236

8.  Synthesis of 2'-deoxy-2'-[18F]fluoro-beta-D-arabinofuranosyl nucleosides, [18F]FAU, [18F]FMAU, [18F]FBAU and [18F]FIAU, as potential PET agents for imaging cellular proliferation. Synthesis of [18F]labelled FAU, FMAU, FBAU, FIAU.

Authors:  Thomas J Mangner; Raymond W Klecker; Lawrence Anderson; Anthony F Shields
Journal:  Nucl Med Biol       Date:  2003-04       Impact factor: 2.408

9.  A new acycloguanosine-specific supermutant of herpes simplex virus type 1 thymidine kinase suitable for PET imaging and suicide gene therapy for potential use in patients treated with pyrimidine-based cytotoxic drugs.

Authors:  Yury Likar; Konstantin Dobrenkov; Malgorzata Olszewska; Elena Vider; Larissa Shenker; Shangde Cai; Nagavarakishore Pillarsetty; Hedvig Hricak; Vladimir Ponomarev
Journal:  J Nucl Med       Date:  2008-04-15       Impact factor: 10.057

10.  Evaluation of 2'-deoxy-2'-flouro-5-methyl-1-beta-D-arabinofuranosyluracil as a potential gene imaging agent for HSV-tk expression in vivo.

Authors:  Mian M Alauddin; Atranik Shahinian; Erlinda M Gordon; Peter S Conti
Journal:  Mol Imaging       Date:  2002 Apr-Jun       Impact factor: 4.488

View more
  9 in total

Review 1.  Modular strategies for PET imaging agents.

Authors:  Jacob M Hooker
Journal:  Curr Opin Chem Biol       Date:  2009-10-31       Impact factor: 8.822

Review 2.  Non-invasive Reporter Gene Imaging of Cell Therapies, including T Cells and Stem Cells.

Authors:  Candice Ashmore-Harris; Madeleine Iafrate; Adeel Saleem; Gilbert O Fruhwirth
Journal:  Mol Ther       Date:  2020-03-20       Impact factor: 11.454

3.  A new pyrimidine-specific reporter gene: a mutated human deoxycytidine kinase suitable for PET during treatment with acycloguanosine-based cytotoxic drugs.

Authors:  Yury Likar; Juan Zurita; Konstantin Dobrenkov; Larissa Shenker; Shangde Cai; Anton Neschadim; Jeffrey A Medin; Michel Sadelain; Hedvig Hricak; Vladimir Ponomarev
Journal:  J Nucl Med       Date:  2010-09       Impact factor: 10.057

Review 4.  In vivo imaging of therapy-induced anti-cancer immune responses in humans.

Authors:  Erik H J G Aarntzen; Mangala Srinivas; Caius G Radu; Cornelis J A Punt; Otto C Boerman; Carl G Figdor; Wim J G Oyen; I Jolanda M de Vries
Journal:  Cell Mol Life Sci       Date:  2012-10-05       Impact factor: 9.261

5.  Positron emission tomography reporter genes and reporter probes: gene and cell therapy applications.

Authors:  Shahriar S Yaghoubi; Dean O Campbell; Caius G Radu; Johannes Czernin
Journal:  Theranostics       Date:  2012-04-10       Impact factor: 11.556

6.  Enhancement of PSMA-Directed CAR Adoptive Immunotherapy by PD-1/PD-L1 Blockade.

Authors:  Inna Serganova; Ekaterina Moroz; Ivan Cohen; Maxim Moroz; Mayuresh Mane; Juan Zurita; Larissa Shenker; Vladimir Ponomarev; Ronald Blasberg
Journal:  Mol Ther Oncolytics       Date:  2016-12-14       Impact factor: 7.200

Review 7.  How Non-invasive in vivo Cell Tracking Supports the Development and Translation of Cancer Immunotherapies.

Authors:  Madeleine Iafrate; Gilbert O Fruhwirth
Journal:  Front Physiol       Date:  2020-04-03       Impact factor: 4.566

8.  Applications of nuclear-based imaging in gene and cell therapy: probe considerations.

Authors:  Alessia Volpe; Naga Vara Kishore Pillarsetty; Jason S Lewis; Vladimir Ponomarev
Journal:  Mol Ther Oncolytics       Date:  2021-02-04       Impact factor: 7.200

9.  Redesigning human 2'-deoxycytidine kinase enantioselectivity for L-nucleoside analogues as reporters in positron emission tomography.

Authors:  Pravin Muthu; Hannah X Chen; Stefan Lutz
Journal:  ACS Chem Biol       Date:  2014-08-13       Impact factor: 5.100

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.